We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
AstraZeneca has unveiled late-stage data backing use of its triple combination therapy PT010 in patients with chronic obstructive pulmonary disease (COPD).
The Mahoney Institute for Neurosciences (MINS) at the University of Pennsylvania is pleased to announce an international call for submissions for the inaugural Rising Star Award in neuroscience research.